40 related articles for article (PubMed ID: 27542841)
1. Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer.
Lu CS; Shieh GS; Wang CT; Su BH; Su YC; Chen YC; Su WC; Wu P; Yang WH; Shiau AL; Wu CL
Oncotarget; 2017 May; 8(19):30844-30858. PubMed ID: 27244887
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin.
Schmit K; Chen JW; Ayama-Canden S; Fransolet M; Finet L; Demazy C; D'Hondt L; Graux C; Michiels C
Cell Death Dis; 2019 Dec; 10(12):919. PubMed ID: 31801939
[TBL] [Abstract][Full Text] [Related]
3. A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models.
Mrdenovic S; Wang Y; Yin L; Chu GC; Ou Y; Lewis MS; Heffer M; Posadas EM; Zhau HE; Chung LWK; Edderkaoui M; Pandol SJ; Wang R; Zhang Y
BMC Cancer; 2023 Jun; 23(1):499. PubMed ID: 37268911
[TBL] [Abstract][Full Text] [Related]
4. Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency.
Reid-Bayliss KS; Arron ST; Loeb LA; Bezrookove V; Cleaver JE
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10151-6. PubMed ID: 27543334
[TBL] [Abstract][Full Text] [Related]
5. Cellular senescence of renal tubular epithelial cells in acute kidney injury.
Chen J; Zhang H; Yi X; Dou Q; Yang X; He Y; Chen J; Chen K
Cell Death Discov; 2024 Feb; 10(1):62. PubMed ID: 38316761
[TBL] [Abstract][Full Text] [Related]
6. YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer.
Su Y; Wang B; Huang J; Huang M; Lin T
Cell Prolif; 2023 Jul; 56(7):e13404. PubMed ID: 37070134
[TBL] [Abstract][Full Text] [Related]
7. Cellular senescence: the good, the bad and the unknown.
Huang W; Hickson LJ; Eirin A; Kirkland JL; Lerman LO
Nat Rev Nephrol; 2022 Oct; 18(10):611-627. PubMed ID: 35922662
[TBL] [Abstract][Full Text] [Related]
8. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
[TBL] [Abstract][Full Text] [Related]
9. XPF expression and its relationship with the risk and prognosis of colorectal cancer.
Hu H; Jing J; Lu X; Yuan Y; Xing C
Cancer Cell Int; 2021 Jan; 21(1):12. PubMed ID: 33407486
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of immune/stromal-related gene biomarkers in renal cell carcinoma.
Wang S; Zheng X; Chen X; Shi X; Chen S
Oncol Lett; 2020 Jul; 20(1):308-316. PubMed ID: 32565957
[TBL] [Abstract][Full Text] [Related]
11. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents.
Zhou J; Kang Y; Chen L; Wang H; Liu J; Zeng S; Yu L
Front Pharmacol; 2020; 11():343. PubMed ID: 32265714
[TBL] [Abstract][Full Text] [Related]
12. Impact of XPF rs2276466 polymorphism on cancer susceptibility: a meta-analysis.
Liu Y; Liu K; Zhao X; Sun Y; Ma N; Tang L; Yang H; Gao X; Yan L; Yuan M; Wang B; Zhang X; Jia J
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31040199
[TBL] [Abstract][Full Text] [Related]
13. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
14. Higher expression of XPF is a critical factor in intrinsic chemotherapy resistance of human renal cell carcinoma.
Zhang Q; Shi J; Yuan F; Wang H; Fu W; Pan J; Huang Y; Yu J; Yang J; Chen Z
Int J Cancer; 2016 Dec; 139(12):2827-2837. PubMed ID: 27542841
[TBL] [Abstract][Full Text] [Related]
15. Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells.
Heyza JR; Arora S; Zhang H; Conner KL; Lei W; Floyd AM; Deshmukh RR; Sarver J; Trabbic CJ; Erhardt P; Chan TH; Dou QP; Patrick SM
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400270
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
Li W; Melton DW
Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
[TBL] [Abstract][Full Text] [Related]
17. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.
Arora S; Heyza J; Zhang H; Kalman-Maltese V; Tillison K; Floyd AM; Chalfin EM; Bepler G; Patrick SM
Oncotarget; 2016 Nov; 7(46):75104-75117. PubMed ID: 27650543
[TBL] [Abstract][Full Text] [Related]
18. Role of Nucleotide Excision Repair in Cisplatin Resistance.
Duan M; Ulibarri J; Liu KJ; Mao P
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291532
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of resistance to cisplatin.
Kartalou M; Essigmann JM
Mutat Res; 2001 Jul; 478(1-2):23-43. PubMed ID: 11406167
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
